Impaired ability to produce IFN-c and IL-2 was exhibited by the majority of tumor-derived TIM-3+ CD4 T cells, and in vitro, they significantly suppressed the proliferation of autologous CD8+ T cells. The gene discussed is CD8A; the disease is neoplasm.